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Introduction: Minimal residual disease is a presence of viable tumor cells       
in the body during or after cancer treatment. These cells can not be detected by usual 
methods. Diagnosis is based on proof of differences between tumor and healthy cells 
using very sensitive methods. In experimental medicine, there is a need for detection 
of human cells in mouse tissues after xenotransplantatio . That's why I introduced      
a sensitive PCR method capable of detecting minimum q antities of human cells       
in animal tissues. 
Material: I worked with human lymphocytes, neuroblastoma cell line, cell line 
derived from Ewing sarcoma, tissue samples from comm nly used laboratory animals 
- mouse, rat, rabbit, monkey, dog, guinea pig and rat b ain tissues from the injection 
site where they were delivered human CD34+ haematopoietic progenitor cells,         
and tissue from the lesions. 
Results: I set the sensitivity of PCR method 1:105 using dilution test.                
In the experiment with various animal’s tissue I showed that the method detect only 
the presence of human DNA. I tried applicability of the method in an experiment      
of monitoring human CD34+ hematopoietic progenitor cells in mice brains. I proved 
that CD34+ cells implanted into the brain migrate to the lesion site. The credibility     
of the results was confirmed by magnetic resonance imaging                                   
and immunohistochemistry. 
Discussion and conclusion: I introduced and in the experiment showed        
that the PCR technique can be used to monitor the fate of transplanted stem cells       
in the host organism. In previous studies stem cells in the bone marrow were marked 
and monitored. Hematopoietic progenitor cells characterized by the presence of CD34 
antigen are the focus of ongoing research. These cells have the capacity for extensive 
self-renewal and pluripotent differentiation and are used medically to ensure long-
term recovery of bone marrow in human patients. 
